Minneapolis Heart Institute, Abbott Northwestern Hospital, MN (M.M., J.J., M.N.B., E.S.B.).
Division of Cardiovascular Medicine, Hennepin Healthcare, Minneapolis, MN (M.M.).
Circ Cardiovasc Interv. 2019 Jun;12(6):e007778. doi: 10.1161/CIRCINTERVENTIONS.118.007778. Epub 2019 Jun 14.
Background Radial access (RA) is increasingly used in chronic total occlusion (CTO) percutaneous coronary intervention with encouraging results. However, there are concerns about its safety and efficacy because of higher complexity and the need for strong guide catheter support. Methods and Results We performed a systematic review and meta-analysis of all studies published through November 2018 reporting the outcomes of RA versus femoral access in CTO percutaneous coronary intervention. Outcomes included major bleeding, access-site complications, in-hospital major adverse events, and technical success. Nine observational studies with 10 590 patients (10 617 lesions) were included in the meta-analysis. CTO lesions attempted using RA had lower Japan-CTO score (2.3±1.2 versus 2.5±1.3; P<0.001). Use of RA was associated with similar technical success (78.7% versus 78.5%; odds ratio, 1.11; 95% CI, 0.94-1.31; P=0.24; I=23%), lower risk of access-site complications (0.73% versus 1.79%; odds ratio, 0.34; 95% CI, 0.22-0.51; P<0.001; I=0%) and major bleeding (0.18% versus 0.9%; odds ratio, 0.22; 95% CI, 0.10-0.45; P<0.001; I=0%), and similar risk of in-hospital adverse events and in-hospital mortality (odds ratio, 0.36; 95% CI, 0.12-1.07; P=0.07; I=0%) as compared to femoral access. Results were similar when analyzing radial-only versus any femoral access and when excluding the largest study. Conclusions As compared with femoral access, RA is used in CTO percutaneous coronary intervention of less complex lesions and is associated with fewer access-site complications and major bleeding and comparable technical success.
桡动脉(RA)入路在慢性完全闭塞(CTO)经皮冠状动脉介入治疗中的应用越来越多,且结果令人鼓舞。然而,由于其复杂性更高,需要强有力的引导导管支持,因此人们对其安全性和有效性存在担忧。
我们对截至 2018 年 11 月发表的所有报告 RA 与股动脉入路在 CTO 经皮冠状动脉介入治疗中结局的研究进行了系统回顾和荟萃分析。结局包括大出血、血管入路并发症、住院期间主要不良事件和技术成功率。共有 9 项观察性研究纳入了 10590 例患者(10617 处病变)的荟萃分析。采用 RA 尝试治疗的 CTO 病变的日本 CTO 评分较低(2.3±1.2 比 2.5±1.3;P<0.001)。RA 的使用与相似的技术成功率相关(78.7%比 78.5%;比值比,1.11;95%CI,0.94-1.31;P=0.24;I=23%),血管入路并发症的风险较低(0.73%比 1.79%;比值比,0.34;95%CI,0.22-0.51;P<0.001;I=0%)和大出血的风险较低(0.18%比 0.9%;比值比,0.22;95%CI,0.10-0.45;P<0.001;I=0%),住院期间不良事件和住院死亡率的风险也相似(比值比,0.36;95%CI,0.12-1.07;P=0.07;I=0%),与股动脉入路相比。当分析桡动脉专用与任何股动脉入路时,以及当排除最大的研究时,结果相似。
与股动脉入路相比,RA 用于 CTO 经皮冠状动脉介入治疗的病变复杂程度较低,血管入路并发症和大出血较少,且技术成功率相当。